Close

BioLineRx (BLRX) Presents Positive Data on Its BL-8040 Cancer Therapy Platform at SOHO

September 17, 2014 7:05 AM EDT Send to a Friend
BioLineRx Ltd. (NASDAQ: BLRX) announced today the presentation of positive preclinical results of its BL-8040 cancer therapy platform, as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login